Yale University

Drug to Treat Alcohol Addiction Also Helps with Suppression of HIV

A medication commonly prescribed to treat alcohol use disorder also appears to help maintain or improve suppression of HIV among individuals at risk for relapse receiving HIV antiretroviral treatment, Yale researchers said.

In a new study, a research team led by Dr. Sandra Springer conducted a placebo-controlled, randomized trial involving individuals incarcerated in Connecticut who had both HIV and alcohol use disorders. Upon release, the 100 study participants were given either extended-release naltrexone - an FDA-approved drug that treats alcohol addiction - or a placebo. The researchers followed the individuals for six months from the time of release.

More from YaleNews



Published: Monday, July 2, 2018